J. Paul Robinson is the SVM Professor of Cytomics in the College of Veterinary Medicine and a professor of biomedical engineering in the Weldon School of Biomedical Engineering at Purdue University. He received his Ph.D. in Immunopathology from the University of New South Wales, Sydney, Australia. He completed a postdoctoral fellowship at the University of Michigan Medical School. He is currently the director of the Purdue University Cytometry Laboratories at Purdue University.
He is a past President of the International Society for Advancement of Cytometry, is the Editor- in-Chief of Current Protocols in Cytometry, Associate Editor of Histochemica et Cytobiologica, and Associate Editor of Cytometry Part A. He is an active researcher with over 166 peer reviewed publications, 32 book chapters, has 7 issued patents with 5 pending, has edited 9 books and has given over 140 international lectures and taught advanced courses in over a dozen countries and made over 370 conference presentations. Robinson was an early adopter of web-based educational materials by publishing one of the first known published web-based-CDROM in April 1996 and since published 15 CD-ROMs or DVDs with a total distribution of around 100,000 copies all distributed free of charge. He was elected to the College of Fellows, American Institute for Medical & Biological Engineering (AIMBE) in 2004, received the Pfizer Award for Innovative Research in 2004 and the Gamma Sigma Delta Award of Merit Research in 2002 and the 2016 College of Veterinary Medicine, Research Excellence Award. He has participated in numerous NIH, NSF and private foundation review boards. He has given a large number of talks and presentations to student groups and community service organizations. He is also a past chair of the Purdue University Senate.
His research area has been focused on reactive oxygen species primarily in neutrophils and cell lines such as HL-60 cells. His lab is currently funded by DARPA, NIH and USDA. Over the past several years, his group has expanded their interest in bioengineering with hardware and software groups developing innovative technologies such as hyperspectral cytometry using multiarray PMTs (commercialized by Sony), optical tools for quantitative fluorescence measurement and advanced classification approaches for clinical diagnostics and bacterial classification (commercialized by Hettich), and high content, high throughput screening technologies. He has also been developing technologies to enhance multiplexed cytometry and technologies that may be valuable for microparticle analysis including developing new supersensitive and high speed photon detectors, and associated electronics. Robinson started a not-for-profit charity, “Cytometry for Life” with the goal of focusing attention on the need for low cost CD4 technology to those nations most in need of these tools (http://www.cytometryforlife.org).
One effort toward bringing attention to the issue of low cost CD4 was his successful Mt. Everest summit on May 23, 2009, at 9:31am (http://www.cyto.purdue.edu/trackpaul/) in his bid to raise awareness of the major issues facing those who are HIV positive. The lack of low cost diagnostic tools has been an important focus of his laboratory activity over recent years.